| Literature DB >> 34873214 |
Aniruddha Agarwal1,2, Gagan Kalra3, Rupesh Agrawal4,5,6,7,8,9,10, Reema Bansal1, Vishali Gupta11.
Abstract
To analyze the longitudinal changes in the outer plexiform layer (OPL) in patients with tubercular serpiginous-like choroiditis (TB SLC) and compare it to the healthy control population. Clinical and imaging data of subjects with TB SLC (minimum 6-month follow-up) and healthy control subjects were reviewed. Optical coherence tomography (OCT) imaging obtained using swept-source device (DRI Triton, Topcon, Japan) from three visits (baseline, 3 months, and 6 months) were analyzed. Three OCT scans were chosen-one passing through the center of the fovea, one line above, and one line below. After random indexing to anonymize the images, they were pre-processed and fed into an automated pipeline to identify, crop, and measure the area of the OPL in the line scan. Longitudinal comparisons of OPL within the patient group were performed. The study included 32 eyes (16 patients; 11 males; mean age: 32.9 ± 7.8 years) with TB SLC. Twenty-eight eyes (14 subjects; 10 males: mean age: 31.1 ± 6.2 years) of healthy control subjects (age- and gender-matched) were also selected. The area of OPL was significantly different between the baseline and month 6 visit (6288 ± 1803 versus 5487 ± 1461; p = 0.0002) at the central scan passing through the fovea. For the scans above and below the fovea, the reduction in OPL area was significant at each visit (p < 0.0001). In comparison with healthy control subjects, OPL area values in patients with TB SLC were significantly lower at the month-3 (6116 ± 1441 versus 7136 ± 2539; p = 0.04) and the 6-month visit (5487 ± 1461 versus 7136 ± 2539; p < 0.001). The atrophied OPL at month 6 has been referred to as the "middle limiting membrane" (MLM). Subjects with TB SLC may develop progressive atrophy of the OPL resulting in formation of MLM, which is seen as a hyper-reflective line replacing the OPL. The analysis of longitudinal changes in the OPL may be useful in predicting anatomical and functional outcomes in these patients.Entities:
Mesh:
Year: 2021 PMID: 34873214 PMCID: PMC8648791 DOI: 10.1038/s41598-021-02894-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The figure shows the algorithm used in the semi-automated quantitative analysis of the outer plexiform layer (OPL) area in the included subjects in our study. The pre-processing stage consisted of randomization, anonymization and cropped using third party software (ImageJ). The subsequent automated stages included conversion to 8-bit and thresholding, and measurement of the area in square pixels.
Figure 2Illustrates the segmentation and cropping of the outer plexiform layer from the optical coherence tomography line scan, and subsequent thresholding for calculation of the area using an automated algorithm on ImageJ.
Demographic and clinical characteristics of patients with tubercular serpiginous-like choroiditis and normal healthy control subjects included in the study.
| Variable | Patients with TB SLC | Normal Healthy Controls | |
|---|---|---|---|
| Number of patients (n) | 16 | 14 | – |
| Age (years ± SD) | 32.94 ± 7.84 | 31.07 ± 6.23 | 0.60 |
| Male (n) | 11 | 10 | 0.87 |
| Female (n) | 5 | 4 | |
| Duration of symptoms (weeks) | 3.81 ± 2.29 | – | – |
| Baseline BCVA (LogMAR) | 0.36 ± 0.21 | 0.07 ± 0.08 | 0.0003 |
| Investigations | – | – | |
| Positive Mantoux* (n) | 13 | ||
| Positive IGRA** (n) | 8 | ||
| Positive CT Chest† (n) | 6 | ||
| Positive biopsy‡ (n) | 2 | ||
| Treatment | – | – | |
| ATT and systemic corticosteroids (n) | 16 |
*Indicates induration ≥ 10 mm × 10 mm by tuberculin skin test after 48–72 h.
**Indicates a positive interferon gamma assay (IGRA) using QuantiFERON TB Gold® test.
†Indicates evidence of healed or active tuberculosis on computerized chest tomography.
‡Indicates biopsy from lung/lymph nodes, or minor salivary glands.
The mean area (± standard deviation) of the outer plexiform layer (OPL) among patients with tubercular serpiginous-like choroiditis (TB SLC) measured using semi-automated quantitative techniques on optical coherence tomography line scans.
| Baseline visit (M1) | Month 3 (M2) | Month 6 (M3) | ||
|---|---|---|---|---|
| Macula | 6288 ± 1803 | 6116 ± 1441 | 5487 ± 1461* | 0.0002 |
| Above | 7614 ± 1509 | 6629 ± 1475* | 5559 ± 1516* † | < 0.0001 |
| Below | 7287 ± 1784 | 6147 ± 1735* | 5176 ± 1655* † | < 0.0001 |
The data is represented in mean pixel square (area) of the outer plexiform layer.
The analysis is performed using one-way repeated measures analysis of variance (ANOVA).
*p < 0.05 vs baseline visit (using post-hoc Tukey’s test).
†p < 0.05 vs month 3 visit (using post-hoc Tukey’s test).
Figure 3A representative figure of a patient with tubercular serpiginous-like choroiditis showing foveal optical coherence tomography (OCT) B-scans at three visits. The foveal OCT B-scan at first visit (top panel) shows a near-normal hyper-reflective outer plexiform layer (OPL). The foveal OCT B-scan at second visit (3 months) shows thinning of the OPL, which has been thrown into undulations (middle panel). The OCT B-scan at third visit (6 months) (bottom panel) shows significant thinning and atrophy, resulting in formation of a middle limiting membrane (white arrowheads).
Comparison between the area of outer plexiform layer (OPL) (in mean pixel square) between patients with tubercular serpiginous-like choroiditis and normal healthy control subjects.
| Patients (n = 32 eyes) | Normal control (n = 28 eyes) | ||
|---|---|---|---|
| M1 | 6827.75 ± 1803.51 | 7135.93 ± 2538.57 | 0.75 |
| M2 | 6115.53 ± 1440.71 | – | |
| M3 | 5486.5 ± 1461.09 | – | |
| M1 | 7613.66 ± 1509.18 | 7513.04 ± 2822.76 | 0.35 |
| M2 | 6628.97 ± 1474.79 | – | 0.11 |
| M3 | 5558.97 ± 1515.95 | – | |
| M1 | 7286.66 ± 1784.21 | 7517.79 ± 2519.80 | 0.73 |
| M2 | 6146.91 ± 1734.83 | – | |
| M3 | 5176.28 ± 1654.71 | – |
M1: Baseline visit.
M2: Intermediate visit at month 3.
M3: Final visit at month 6.
The p value was calculated by using Mann–Whitney U test.
Significant values are in bold.